PR Newswire | 21 days 17 hours 21 minutes ago
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Quarter 2009 Financial Results Call Set for November 10
VENLO, Netherlands, Nov. 3 /PRNewswire-FirstCall/ -- QIAGEN N.V.
What: Webcast of QIAGEN's third quarter 2009 financial results call
When: 9:30 a.m. EST on November 10
Where: The Webcast is accessible at www.qiagen.com/goto/ConferenceCall
How: Log on to the Web at the address above
The corresponding presentation slides are available for download in the investor relations section of QIAGEN's Web site at www.qiagen.com/goto/ConferenceCall.
Contact: Andreas Marathovouniotis, Russo Partners, (212) 845-4235
QIAGEN N.V., a Netherlands holding company, is the leading provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 consumable products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include what is considered to be the broadest panel of molecular diagnostic tests available worldwide. This panel includes the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer.
QIAGEN employs more than 3,200 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.qiagen.com.
(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from http://www.real.com/products/player/index.html, or The Windows Media Player, downloadable free from www.microsoft.com and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an email to
CONTACT: Andreas Marathovouniotis, Russo Partners, +1-212-845-4235
Web site: http://www.qiagen.com/
Articles appearing above are picked up from PR Newswire's feed. Stories from this feed are submitted by companies, edited and rereleased as a service of PR Newswire.
Sign up for AdvaMed SmartBrief
Companies mentioned